tci Medicare Compliance & Reimbursement - 2020 Issue Q2
Industry Notes: Post COVID-19 Testing Prices Upfront
Subscribe or sign in to view the full article.
Article Overview
This article explains a CMS reminder about public posting of cash prices for COVID-19 diagnostic testing and the federal compliance context behind that requirement. It is relevant to healthcare organizations, billing and compliance teams, and providers that offer diagnostic testing and need to understand the general regulatory and enforcement landscape. The note also references the CARES Act and CMS FAQ guidance without delving into coding specifics.
Why This Topic Matters
Organizations that perform COVID-19 diagnostic testing need to understand federal transparency obligations and the potential consequences of noncompliance. The article helps compliance and revenue cycle teams recognize the general policy area and the type of CMS guidance involved.
What You Will Learn
- The general federal requirement for posting cash prices for COVID-19 diagnostic testing
- The CMS and CARES Act context for price transparency guidance
- The types of compliance consequences mentioned for noncompliance
- Where the referenced CMS FAQ guidance can be found
Who Should Read This
- Healthcare providers
- Compliance teams
- Revenue cycle staff
- Billing professionals
- Practice administrators
Subscribe or sign in to view the full article.
Thank you for choosing Find-A-Code, please Sign In to remove ads.


Quick, Current, Complete - www.findacode.com